The Nuffield Council on Bioethics warmly welcomes news of the Health Research Authority (HRA) public involvement service for COVID-19 studies.
All applicants for HRA approvals for COVID-19 research are strongly encouraged to involve people with relevant lived experience in the design, conduct, and dissemination of their studies. To support this, the HRA has established a public involvement matching service to connect researchers and public involvement networks. As of 4 June, the database has details of 21 networks across the UK ready to support COVID-19 research.
The Nuffield Council is a strong proponent of community and patient engagement in research. We believe that involving people at all stages of research is a vital part of conducting research ethically. We are pleased to share the news of this important and timely HRA initiative.
Just at the point where vaccine trials are showing promise, levels of infection circulating in the general population in the UK are relatively low. This is obviously good news from many perspectives – but makes the next stage of testing more difficult. Is one possible answer human challenge trials?
24 Jul 2020
- Rapid policy briefing: COVID-19 antibody testing and ‘immunity certification’
- Rapid policy briefing: Fair and equitable access to COVID-19 treatments and vaccines
- Rapid policy briefing: Responding to the COVID-19 pandemic - ethical considerations
- Guide to the ethics of surveillance and quarantine for novel coronavirus
Ongoing series of activities
Access our resources related to the COVID-19 pandemic.
23 Jun 2020
COVID-19 antibody testing and 'immunity certification': a discussion paper
This paper was prepared as background to inform the Nuffield Council on Bioethics policy briefing on COVID-19 antibody testing and immunity certification. The paper is intended to provide a more detailed overview of key ethical, social and policy issues, and is published to further promote and stimulate discussion of the issues that it identifies.